Prof. Dr. Lei Zhang is a leading researcher in cancer pharmacology, nanomedicine, and biomaterials, recognized for her contributions to understanding and overcoming tumor multidrug resistance. Her research focuses on the molecular mechanisms of ABC transporter–mediated drug resistance, PI3K/CDK signaling pathways, and the development of targeted nano- and bio-material–based drug and gene delivery systems. She has produced high-impact research in internationally renowned journals, with several publications ranked among top-tier oncology and materials science outlets. Her work integrates structural biology, chemical biology, and translational pharmacology to advance precision cancer therapeutics. Prof. Zhang is also active in innovation-driven research, contributing to patented technologies and interdisciplinary R&D platforms that translate fundamental discoveries into clinically relevant strategies for resistant and metastatic cancers.